Announcement of TTY Biopharm's unaudited income information in September 2025
2025.10.16
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2025/10/16 | Time of announcement | 17:17:51 |
| Subject | Announcement of TTY Biopharm's unaudited income information in September 2025 | ||||
| Date of events | 2025/10/16 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2025/10/16 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:As disclosed in the Company’s material information announcement dated January 21, 2025, more than half of the settlement compensation received will be reserved to cover estimated expenses, including litigation costs, and only the remaining portion shall be recognized as non-operating income. Based on the foregoing explanation, the recognition ratio previously applied was incorrect. Therefore, the Company hereby corrects the self-prepared consolidated financial results for September 2025,originally announced on October 14, 2025, as follows. TTY Biopharm posted a consolidated income before tax of NT$482,551 thousands (expressed in NT dollars; unaudited) in September 2025, instead of NT$593,809 thousands as previously reported. Net income attributable to stockholders of the Company was NT$368,212 thousands, instead of NT$457,218 thousands, and EPS was NT$1.48, instead of NT$1.84. Year-to-date consolidated income before tax was NT$1,678,857 thousands until September 2025, instead of NT$1,790,114 thousands, and year-to-date net income attributable to stockholders of the Company was NT$1,255,910 thousands,instead of NT$1,344,915 thousands. Accordingly, EPS was NT$5.05, instead of NT$5.41. 6.Countermeasures:Publish a material information announcement on the Market Observation Post System (MOPS) and re-upload the corrected amount. 7.Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): (1)The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. (2)The out-of-court settlement between TTY and Inopha AG (Switzerland) and its material beneficiary, Mr. Denis Opitz, revenue has been fully recognized as of this month. |
||||